BlackRock’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Sell |
716,297
-1,597,503
| -69% | -$663K | ﹤0.01% | 4502 |
|
|
2025
Q1 | $1.44M | Sell |
2,313,800
-70,447
| -3% | -$43.9K | ﹤0.01% | 4043 |
|
|
2024
Q4 | $3.98M | Sell |
2,384,247
-217,529
| -8% | -$363K | ﹤0.01% | 3771 |
|
|
2024
Q3 | $4.74M | Sell |
2,601,776
-85,843
| -3% | -$156K | ﹤0.01% | 3669 |
|
|
2024
Q2 | $16.2M | Buy |
2,687,619
+466,058
| +21% | +$2.81M | ﹤0.01% | 3057 |
|
|
2024
Q1 | $24.8M | Sell |
2,221,561
-13,532
| -0.6% | -$151K | ﹤0.01% | 2813 |
|
|
2023
Q4 | $33.3M | Buy |
2,235,093
+392,074
| +21% | +$5.84M | ﹤0.01% | 2685 |
|
|
2023
Q3 | $8.85M | Buy |
1,843,019
+54,259
| +3% | +$260K | ﹤0.01% | 3356 |
|
|
2023
Q2 | $13.4M | Buy |
1,788,760
+120,136
| +7% | +$902K | ﹤0.01% | 3203 |
|
|
2023
Q1 | $7.54M | Sell |
1,668,624
-32,462
| -2% | -$147K | ﹤0.01% | 3390 |
|
|
2022
Q4 | $19.2M | Buy |
1,701,086
+30,684
| +2% | +$346K | ﹤0.01% | 3001 |
|
|
2022
Q3 | $16M | Buy |
1,670,402
+8,120
| +0.5% | +$77.7K | ﹤0.01% | 3105 |
|
|
2022
Q2 | $13.4M | Buy |
1,662,282
+306,804
| +23% | +$2.48M | ﹤0.01% | 3270 |
|
|
2022
Q1 | $22.9M | Buy |
1,355,478
+14,907
| +1% | +$252K | ﹤0.01% | 3022 |
|
|
2021
Q4 | $28.8M | Sell |
1,340,571
-26,190
| -2% | -$563K | ﹤0.01% | 2982 |
|
|
2021
Q3 | $101M | Buy |
1,366,761
+114,456
| +9% | +$8.45M | ﹤0.01% | 2184 |
|
|
2021
Q2 | $68.5M | Sell |
1,252,305
-266,175
| -18% | -$14.6M | ﹤0.01% | 2454 |
|
|
2021
Q1 | $112M | Buy |
1,518,480
+145,731
| +11% | +$10.7M | ﹤0.01% | 2113 |
|
|
2020
Q4 | $118M | Buy |
1,372,749
+543,735
| +66% | +$46.9M | ﹤0.01% | 1957 |
|
|
2020
Q3 | $31.3M | Buy |
+829,014
| New | +$31.3M | ﹤0.01% | 2527 |
|